KAJIAN SAINS TENTANG BARAH DAN TRANFER FACTOR.
SILA BACA UNTUK ILMU.
CANCER RESEARCH – CHEMOTHERAPY AND REAL THERAPIES
“The medical establishment works closely with the drug multinationals whose main objective is profits, and whose worst nightmare would be an epidemic of good health. Lots of drugs MUST be sold. In order to achieve this, anything goes: lies, fraud, and kickbacks. Doctors are the principal salespeople of the drug companies. They are rewarded with research grants, gifts, and lavish perks. The principal buyers are the public – from infants to the elderly – who MUST be thoroughly medicated and vaccinated…at any cost!”
“Why do the authorities forbid alternative medicine? Because they are serving the industry, and the industry cannot make money with herbs, vitamins, and homeopathy. They cannot patent natural remedies. That is why they push synthetics. They control medicine, and that is why they are able to tell medical schools what they can and cannot teach.” Guylaine Lanctot, M.D
Effect of Transfer Factor
Containing E-XF Blends on
Natural Killer (NK) Cell
A 4Life Summary of an Independent NK
Cell Study Report by Calvin W.
McCausland, Ph.D. and Emma Oganova
To determine the extent to which Transfer Factor E-XF blends and 4Life Transfer Factor Plus Advanced Formula increases Natural Killer (NK) cell activity above
cytotoxicity study was designed by Dr.E. Oganova and Dr. C. McCausland.
The independent testing of the coded samples was done under the direction
of Academician Anatoly Vorobiev, M.D., Russian Academy of Medical
Sciences (RAMS) and the experimental work was conducted by.
Dr. M.V. Kisielevsky, Dr. E.O. Khalturina, at the Russian Cancer
Research Center, RAMS
Methods: Blood was obtained from RORC donor station. A standard
for 24 or 48 hours. Next 30 thousand K-562 tumor cells (erythroblastic human leukemia) were introduced into the wells. (Thus, the ratio of effector and target cells was 2:1. Each sample was tested in triplicate). The preparations containing both the effector (NK cells) and target cells (K562 cancer cells) along with control wells were again incubated for 18-24 hours under the same incubator conditions. AnMTT (dye) solution was used to spectro-photometricly determine the number of viable cells remaining in each well. The cytotoxic index (CI) expressed in % is reported for each
Results: Each of the samples significantly increased NK cellactivity. The Transfer Factor E-XF Blend (Advanced Formula) resulted in method of density gradient was used to isolate mononuclear cells [NK Cells].The isolated cells, 60 thousand cells
per well, in 100 ml of culture medium,were introduced into each well ofCostar 96 well plates. Then, portions of coded test samples [Transfer Factor
E-XF blends of selected ratios, 4Life Transfer Factor Plus E-XF blend and
others samples] were introduced into the wells at predetermined
concentrations (wt/vol.). An Interleukin-2 (IL-2) standard was used to compare effectiveness. The preparations were incubated in a COzincubator with a 5% C02 atmosphere, 100% humidity and 37° C greater NK cell activation (283%) than
the Transfer Factor XF (204%). 4Life Transfer Factor Plus Advanced
Formula increased NK cell activity by 437%. The drug IL-2 increased NK
cell active by 389%. In the study activation by 4Life Transfer Factor
Advanced Formula, 4Life Transfer Factor Plus Advanced Formula and IL-
2 resulted in a kill rate of K562 cancer cells of 69%, 97% and 88%
respectively with the 48 hour incubation period giving the greatest NK cell activation.
As previously reported in earlier publications two 4Life products, 4Life
Transfer Factor Classic and 4Life Transfer Factor Plus, have been
shown to significantly improve NK cell activation, 103% and 248%
respectively. When the transfer factors from patented egg technology
are combined with bovine transfer factors there is a synergistic
activation ofNK cell activity. The improved formulas, 4Life Transfer
Factor and 4Life Transfer Factor Plus Advanced Formulas improve NK
cell activation by 283% and 437% respectively.
4Life researchers and scientists in developing the Advanced Formulas
were confident that the colostrum derived transfer factors when
combined with the egg derived transfer factors (E-XF blends) would
enhance the activity and benefit of the products, but we too were taken
by surprise by the magnitude of the increase. Further research needs to
be done to better understand why this synergism occurs. We are
confident these results will translate into increased benefits to
consumers and increased clinical effect in future studies.
This study was conducted under the direction of Dr. Anatoli Vorobiev
by his colleagues of the Russian Academy of Medical Science. Using
established methods ofcytotoxicity testing, NK cells from humans were
combined with cancer cells and divided into groups of transfer factors
activated NK cells and groups ofunactivated NK cells. The objective
was to find the bovine and egg transfer factor blend(s) (E-XF blends)
that express the greatest NK cell activation. The results enable us to
identify the most potent combination that will provide the greatest
In the control series of the experiments for all of the transfer factor
samples tested there was no direct cytotoxic effect on tumor cells at
any of the concentrations tested. When in the absence of the immune
NK cells the transfer factors are combined directly with the cancer cells
there is no cytotoxic effect on the tumor cells.
Results of this study clearly demonstrated that 4Life Transfer Factor
Advanced Formula and 4Life Transfer Factor Plus Advanced Formula
boosts NK cell activity. The independent research scientists who
conducted this study found the results interesting and so exceptional as
to request further information on the identity of 4Life samples so that
results could be published in professional journals. Statements from
researchers included the following:
“The 4Life sample activated NK cell activity more than the Interleukin-
2 (IL-2) drug used as the standard. Here, we now refer to your sample
as the Golden Interleukin,” stated Dr. Kisielevsky, Russian Academy of
We strongly believe that these results are certain to be reflected in
improved human health resulting from significantly improved immune
response. It is our hope that people everywhere will find that 4Life
Transfer Factor Advanced Formula and 4Life Transfer Factor Plus
Advanced Formula will provide safe broad-spectrum immune support
that is unmatched in any other health supplement today.
Darryl See, M.D.
Speaking at Convention 2001, Dr. Darryl See, a research scientist who has published over 30 peerreviewed journal articles on chronic viral illnesses and immunological disorders, addressed the audience with come incredibly powerful information regarding Transfer Factor. With a medical degree from the University of California at Irvin and a board certification in both Internal Medicine and Infectious Disease, Dr, See’s studies on Transfer Factor add a vast array of credibility to the
unprecedented impact of this exclusive product.
Dr. See conducted the independent in vitro study that tested hundreds of natural products for their
ability to raise natural killer cell activity, including Transfer Factor and Transfer Factor Plus. Natural killer cells work on the front-line of our immune system, destroying harmful cells through direct contact.
As a result of that study, Dr. See concluded that 4Life Transfer Factor and Transfer Factor Plus far outperformed the competition. Transfer Factor raised Natural Killer (NK) Cell Activity by 102 percent and Transfer Factor Plus raised activity by 248 percent.
Recently, Dr. See conducted another study, this time in late stage cancer patients with a regime that included Transfer Factor Plus. He presented the results of this study at the 4Life National Convention. Dr. See again tested NK cell function, as well as the Tumor Necrosis Factor (TNF) in patients. Tumor Necrosis Factor alpha is a cytokine produced primarily by monocytes and macrophages. Also, It is found in synovial cells. It is a substance that has antitumor effects.
INCREASED TUMOR NECROSIS FACTOR ALPHA AND NK CELL FUNCTION
USING AN INTEGRATIVE APPROACH IN LATE STAGE CANCERS
PATIENT DEMOGRAPHICS PATIENT REGIME INCLUDED RESULTS AFTER SIX MONTHS
Average age: 49.3
All stage 4 cancers
12 males, 8 females
Prognosis from physician: 3.7 months to live
Transfer Factor Plus, Beta Glucans, soy extract, digestive enzymes, vegetarian,
low-sugar diet, hyperthermia and more. Average Tumor Necrosis Factor alpha
(TNF) increased from 12.4 to 1287.5 Average increase in NK cell function:
6.4 to 27.6
Sixteen out of the 20 patients studied are in remission, either improving or in stable condition. Dr. See stated that Transfer Factor Plus was an essential part of the regimen.
When they removed it, the patients’ progress began to slow down. Commenting about the Transfer Factor Plus,
Dr. See said, ”Nothing has ever come close to TF Plus in efficacy …I think everyone in the world should be on this product.”Note: These results are from Dr. See’s independent study. These statements have not been evaluated by the FDA.
These products are not intended to diagnose, treat, cure or prevent any disease.
Darryl See, M.D. – Keynote Speaker
BERMINAT UNTUK MENCUBA?? HUBUNGI SAYA DI 0163581794/0163153132 IBRAHIM
blog ilmu saya http://helplineenterprise.wordpress.com
1 Comment »
- 4life done it .
- body losyen
- buah pinggang
- darah tinggi
- imun sisitem
- kulit sensitif
- produk kulit
- produk penjagaan kulit
- sakit kulit
- tranfer factor